MFX
2 known investors
MFX develops the Cyto Engine, an automated bioprocessing platform that accelerates development and manufacturing of engineered cells for cell and gene therapy. The platform combines scalable bioprocessing with analytics and data tools to increase access to these therapies.
Investors · 2
Frequently asked questions
- What does MFX do?
- MFX develops the Cyto Engine, an automated bioprocessing platform that accelerates development and manufacturing of engineered cells for cell and gene therapy. The platform combines scalable bioprocessing with analytics and data tools to increase access to these therapies.
- Who are MFX's investors?
- MFX's investors include Cambridge Angels group, Longwall Venture Partners LLP.